Paper Details

  1. Home
  2. Paper Details

[Pharmacology of anti-platelet agents].

Author: GaillardJ L, KherA, LecompteT, SamamaM

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Antiplatelet agents, like aspirin, are being explored for their ability to modify platelet behavior. While aspirin inhibits thromboxane formation, it also inhibits PGI2, a substance that prevents aggregation. Further research focuses on understanding sulfinpyrazone's varying effects and developing more effective antithrombotic combinations.
Paper Details　
Original Abstract of the Article :
A new class of drugs has appeared alongside classical anti-thrombotic agents such as heparin and oral anticoagulants, characterised by their ability to modify the behaviour of platelets: "anti-platelet" agents. This article reviews the platelet actions, pharmacokinetics, conditions of use and side e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6302191

データ提供：米国国立医学図書館（NLM）

Unraveling the Mysteries of Anti-Platelet Agents: A Journey Through the Desert of Thrombosis

Thrombosis, like a sandstorm, can be a dangerous and unpredictable force. This article delves into the fascinating world of anti-platelet agents, a class of drugs that help prevent blood clots. The article explores the mechanisms of action, pharmacokinetics, and clinical applications of four key anti-platelet agents: acetylsalicylic acid (ASA), sulfinpyrazone, dipyridamole, and ticlopidine. It highlights the challenges and opportunities in developing more effective and targeted anti-platelet therapies.

Navigating the Desert of Thrombosis: A Quest for Effective Anti-Platelet Therapies

The article emphasizes the need for a deeper understanding of the complex mechanisms underlying platelet aggregation and the development of thrombosis. It highlights the ongoing efforts to develop new anti-platelet agents with improved efficacy and safety profiles.

Anti-Platelet Therapies: A Vital Tool in Preventing Thrombosis

This article serves as a valuable resource for clinicians and researchers interested in the field of anti-platelet therapies. It provides a comprehensive overview of the current landscape, emphasizing the ongoing quest for more effective and safe treatments for thrombosis.

Dr. Camel's Conclusion

This article is like a caravan traveling through the desert of thrombosis, carrying valuable knowledge about anti-platelet therapies. The journey to understand and manage thrombosis is ongoing, and this article provides valuable insights into the complex mechanisms of platelet aggregation and the potential of new anti-platelet therapies to prevent this dangerous condition.

Date :
  1. Date Completed 1983-06-10
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

6302191

DOI: Digital Object Identifier

6302191

Related Literature

Article Analysis
・Side Effects of sulfinpyrazone
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.